FELIPE
COUÑAGO LORENZO
Investigador en el període 2012-2022
Publicacions (78) Publicacions de FELIPE COUÑAGO LORENZO
2024
-
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66
-
Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center
Brachytherapy
-
Is trimodal therapy the current standard for muscle-invasive bladder cancer?
Actas Urologicas Espanolas
2023
-
Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis
Clinical Oncology, Vol. 35, Núm. 12, pp. e676-e688
-
Coronavirus disease 2019 and lung cancer: where are we?
Exploration of Targeted Anti-tumor Therapy, Vol. 4, Núm. 5, pp. 1082-1094
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
-
Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review
Biomedicines, Vol. 11, Núm. 1
-
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer
Oncology (Switzerland), Vol. 101, Núm. 6, pp. 349-357
-
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer
Clinical Genitourinary Cancer, Vol. 21, Núm. 6, pp. e485-e494
-
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103
-
PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?
Clinical and Translational Imaging, Vol. 11, Núm. 3, pp. 241-254
-
Prostate Cancer: Management of Biochemical Recurrence after Surgery
Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 733-745
-
Radiogenomics in lung cancer: Where are we?
Lung Cancer, Vol. 176, pp. 56-74
-
Radioterapia en etapas precoces del cáncer de pulmón
Revisiones en Cancer, Vol. 37, Núm. 3, pp. 133-147
-
Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer
Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 718-732
-
Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Clinical Oncology, Vol. 35, Núm. 3, pp. 163-176
-
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions
World Journal of Urology, Vol. 41, Núm. 11, pp. 3333-3344
-
Stereotactic body radiation therapy for kidney cancer. Where do we stand?
International Journal of Urology, Vol. 30, Núm. 5, pp. 437-445
-
Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review
Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768
2022
-
Bone health and therapeutic agents in advanced prostate cancer
Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1